Rubric Capital Management (New York)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,656,847
Closed -$6.83M 76
2024
Q2
$6.83M Hold
2,656,847
0.18% 57
2024
Q1
$13.1M Buy
2,656,847
+1,195,373
+82% +$5.88M 0.39% 54
2023
Q4
$12.8M Sell
1,461,474
-138,526
-9% -$1.22M 0.27% 44
2023
Q3
$18.4M Buy
+1,600,000
New +$18.4M 0.69% 35